Our laboratory has previously identified a novel positive feedback loop involving YAP and CD44, in which CD44 functions as both an upstream regulator and a downstream effector of YAP through RhoA regulation in hepatocellular carcinoma (HCC)24. This evidence concerns the gene CD44 and hepatocellular carcinoma.